RAD21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.88657986402541E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.02140518265514E-14 |
Normal-vs-Stage2 |
4.40190000006169E-07 |
Normal-vs-Stage3 |
2.66453525910038E-15 |
Normal-vs-Stage4 |
5.37959999991067E-07 |
Stage1-vs-Stage2 |
9.184800E-01 |
Stage1-vs-Stage3 |
3.085900E-02 |
Stage1-vs-Stage4 |
9.857400E-01 |
Stage2-vs-Stage3 |
1.618790E-01 |
Stage2-vs-Stage4 |
9.293800E-01 |
Stage3-vs-Stage4 |
2.311000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.44009282066327E-15 |
Normal-vs-AfricanAmerican |
3.70403707705691E-12 |
Normal-vs-Asian |
2.066200E-01 |
Caucasian-vs-AfricanAmerican |
1.440170E-01 |
Caucasian-vs-Asian |
1.290050E-01 |
AfricanAmerican-vs-Asian |
3.192100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.55111512312578E-16 |
Normal-vs-Female |
1.66220370800829E-11 |
Male-vs-Female |
1.185600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.72340000004212E-06 |
Normal-vs-Age(41-60Yrs) |
7.84705633805061E-13 |
Normal-vs-Age(61-80Yrs) |
8.99280649946377E-15 |
Normal-vs-Age(81-100Yrs) |
6.29080010305927E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.169600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.942000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.437800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.073800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.226000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.409830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.145520E-02 |
Normal-vs-Grade 2 |
1.67600378020438E-11 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
2.53280000306333E-08 |
Grade 1-vs-Grade 2 |
3.906000E-01 |
Grade 1-vs-Grade 3 |
3.872000E-02 |
Grade 1-vs-Grade 4 |
7.076200E-02 |
Grade 2-vs-Grade 3 |
5.555600E-03 |
Grade 2-vs-Grade 4 |
1.634600E-01 |
Grade 3-vs-Grade 4 |
9.707600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.985900333068E-11 |
Normal-vs-ccB subtype |
2.79742895514801E-12 |
ccA subtype-vs-ccB subtype |
1.243560E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.07212066686225E-14 |
Normal-vs-N1 |
1.431650E-02 |
N0-vs-N1 |
7.160800E-01 |
|
|